Ramachandran Radhakrishnan
Ramachandran Radhakrishnan (Ram) has nearly three decades of experience in the Pharmaceuticals and Chemicals space. He has held a variety of senior positions with progressively increasing responsibilities in the Pharmaceutical industry in India, USA and Europe. He was until 2005, the Executive Director and a member of the Board of Directors at Strides Arcolab Limited - a listed healthcare company.
Ram has been an entrepreneur since 1983, and has been keenly involved in turning around sick and problematic companies.
His last assignment of over 10 years was as part of a three member senior management team at Strides Arcolab Limited (SAL). He was actively involved in and was instrumental in the growth of the company. He was in charge of the 'Steriles Division' of the company initially and later was Head of Operations of the Contract Research and Manufacturing (CRAM) business at SAL, in which he was involved right from its acquisition. He was instrumental in the acquisition of the US business and was in charge of its operations till 2005.
Ram has been an entrepreneur since 1983, and has been keenly involved in turning around sick and problematic companies.
His last assignment of over 10 years was as part of a three member senior management team at Strides Arcolab Limited (SAL). He was actively involved in and was instrumental in the growth of the company. He was in charge of the 'Steriles Division' of the company initially and later was Head of Operations of the Contract Research and Manufacturing (CRAM) business at SAL, in which he was involved right from its acquisition. He was instrumental in the acquisition of the US business and was in charge of its operations till 2005.
Ramachandran Radhakrishnan
Co-Founder
Akash Mathur
Akash has more than 2 decades of experience start-up and turning around Pharma businesses, including a microarray based start-up in USA and a discovery Pharma company in Canada. He has held senior positions at various organisations including TATA and Dr. Reddys. His last assignment was as CEO of Bal Pharma Ltd; a listed company.
He holds a PhD in Human Pathology from St Louis University and an MBA in Marketing from Olin Business School, Washington University and brings strong Sales, Marketing and profitability approaches to businesses.
He holds a PhD in Human Pathology from St Louis University and an MBA in Marketing from Olin Business School, Washington University and brings strong Sales, Marketing and profitability approaches to businesses.
Dr. Akash Mathur
Co-Founder
Pottayil G Sasikumar
Sasikumar has more than 18 years of experience working with peptide therapeutics. He has led the services collaboration team for several global clients. He has several patents to his credit and is the co-Inventor of drugs in cancer immunotherapy.
Dr. Pottayil G Sasikumar
Co-Founder
Gundala Chennakrishna
14 years experience in Pharma industry in peptide chemistry Extensive experience in peptide route optimization and scale up Co-inventor of multiple patents in cancer immunotherapy
Dr. Gundala Chennakrishna
Co-Founder